A peer support program for the long-term maintenance of physical activity and health outcomes in breast, prostate and colorectal cancer survivors

ABSTRACT: Interventions: Randomised controlled intervention will compare peer support versus no peer support. Prior to randomisation all participants will complete a 4-week training program, supervised by an Accredited Exercise Physiologist or equivalent. This initial program required 3 times per week using a high-intensity interval training protocol of 4x4min intervals at 85-95% HRpeak, with 3 minute active recovery bouts in between. This protocol is a total of 38 minutes in duration. The purpose of this period is to ensure all participants understand the exercise protocol and are able to complete it safely during the maintenance phase. Participants will then be randomised. Participants whom receive peer support will be paired with a peer supporter (a breast, prostate or colorectal cancer survivor) who have undergone training to provide specific support to their peers in the respect of building motivation, enhancing confidence and knowledge of practice and facilitating the enhancement of self-efficacy. This training is provided by Cancer Council Queensland’s peer support team, whom have a program targeted at teaching ‘how to peer support’, specific for cancer patients and survivors. This training will be a 1-day long training. Peer supporters will provide support to their partner 3 times per week for a 12-month period. Peer supporters will be asked to contact their participant at least once per week face-to-face, with additional support provided by either phone, email, text or an additional face-to-face contact. There is no minimum requirements for how detailed these 3 contacts must be; however, peer supporters will keep a log of the date and type of contact given to their participant. Participants will be recruitment from the Brisbane area, with the intervention being run from the Univers Primary outcome(s): Adherence to physical activity and exercise (composite outcome). Objectively measured using the Actigraph GT3X+ accelerometer and logbook. These measured will be assessed to understand globally adherence to physical activity/ exercise during the maintenance phase. [Participants will wear the waist worn device for 7 days immediately before each testing occasion. Testing time-points will be at baseline (prior to supervised training), following the 4-weeks supervised training (i.e. week 5), and at 3-, 6-, and 12- months (primary endpoint) following randomisation. The training logbook will be collected following the participants 12-month testing. ] Study Design: Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy

DISEASE(S): Cancer-bowel-anal,Cancer-bowel-small Bowel (duodenum And Ileum),Colorectal Cancer,Cancer-bowel-back Passage (rectum) Or Large Bowel (colon),Prostate Cancer,Cancer-prostate,Breast Cancer,Cancer-breast

PROVIDER: 2468246 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR